Skip to main content
. 2020 Apr;10(2):193–200. doi: 10.21037/cdt.2020.01.12

Table 3. Incidence of complications within 30 days after ASA in G+ and G− patients.

Adverse event Genotype+ (n=30) Genotype− (n=99) P value
Death [%] 0 [0] 0 [0] NA
Stroke [%] 0 [0] 0 [0] NA
Ventricular tachycardia/fibrillation [%] 1 [3] 4 [4] 0.99
Complete heart block [%] 2 [7] 20 [20] 0.10
Permanent pacemaker implantation [%] 1 [3] 8 [8] 0.68
Cardiopulmonary resuscitation [%] 1 [3] 4 [4] 0.99
Vascular access complication [%] [0] 2 [2] 0.99